VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 41 filers reported holding VERONA PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,983,237 | -22.9% | 6,317,990 | 0.0% | 2.03% | -19.6% |
| Q2 2023 | $133,562,309 | +5.3% | 6,317,990 | 0.0% | 2.52% | -12.2% |
| Q1 2023 | $126,865,239 | -23.2% | 6,317,990 | 0.0% | 2.87% | -14.2% |
| Q4 2022 | $165,089,079 | +167.0% | 6,317,990 | +4.4% | 3.35% | +153.8% |
| Q3 2022 | $61,831,000 | +189.3% | 6,050,000 | +18.6% | 1.32% | +131.4% |
| Q2 2022 | $21,369,000 | -16.0% | 5,100,000 | 0.0% | 0.57% | +2.7% |
| Q1 2022 | $25,449,000 | -25.7% | 5,100,000 | 0.0% | 0.56% | -8.1% |
| Q4 2021 | $34,272,000 | +22.6% | 5,100,000 | 0.0% | 0.60% | +56.1% |
| Q3 2021 | $27,948,000 | -16.2% | 5,100,000 | 0.0% | 0.39% | -27.7% |
| Q2 2021 | $33,354,000 | -21.8% | 5,100,000 | 0.0% | 0.54% | -16.8% |
| Q1 2021 | $42,636,000 | +34.0% | 5,100,000 | 0.0% | 0.64% | +44.5% |
| Q4 2020 | $31,824,000 | 0.0% | 5,100,000 | 0.0% | 0.44% | -23.5% |
| Q3 2020 | $31,824,000 | – | 5,100,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,111,112 | $7,467,000 | 18.90% |
| Abingworth LLP | 2,457,499 | $16,318,000 | 3.95% |
| Aisling Capital Management LP | 1,332,485 | $8,954,000 | 3.16% |
| Fairmount Funds Management LLC | 926,602 | $6,227,000 | 2.05% |
| Ghost Tree Capital, LLC | 750,000 | $5,040,000 | 1.81% |
| Samsara BioCapital, LLC | 1,111,112 | $7,467,000 | 1.45% |
| Vivo Capital, LLC | 2,749,918 | $18,479,000 | 1.11% |
| NEA Management Company, LLC | 5,108,563 | $34,330,000 | 0.69% |
| RA Capital Management | 5,100,000 | $34,272,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 801,256 | $5,384,000 | 0.59% |